DD This was in the Australian 30/5 . Mesoblast's products have the potential to help repair any damaged tissue or organ.
The company recently finished phase II trials applying its product to bone marrow transplants and heart failure, and Mr Itescu is confident phase III trials for both will start early next year. Cheers V
- Forums
- ASX - By Stock
- MSB
- another article in the australian
another article in the australian, page-14
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.26 |
Change
0.000(0.00%) |
Mkt cap ! $1.432B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4580 | $1.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.19 | 1059 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4580 | 1.310 |
1 | 387 | 1.295 |
1 | 4000 | 1.260 |
5 | 31767 | 1.255 |
3 | 14793 | 1.250 |
Price($) | Vol. | No. |
---|---|---|
1.190 | 786 | 1 |
1.195 | 650 | 1 |
1.200 | 978 | 1 |
1.215 | 3711 | 4 |
1.230 | 10000 | 1 |
Last trade - 09.46am 25/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
Day chart unavailable
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online